Neoplasms, Colorectal Recruiting Phase 2 Trials for Tucatinib (DB11652)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03043313Tucatinib (ONT-380) and Trastuzumab in Treating Patients With HER2+ Metastatic Colorectal CancerTreatment